Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mitomycin C and ionizing radiation

Cytogenetic and Genome Research

Volumn 119, Issue 3-4, 2007, Pages 191-195

  Mohseni Meybodi, A ^a   Mozdarani, H ^a   Vosough, P ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BUTADIENE DIEPOXIDE; MITOMYCIN C;

ADOLESCENT; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FANCONI ANEMIA; FEMALE; GAMMA IRRADIATION; GAMMA RADIATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; IONIZING RADIATION; LYMPHOCYTE; MALE; METAPHASE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; SCHOOL CHILD; SENSITIVITY ANALYSIS;

ADULT; CASE-CONTROL STUDIES; CHILD; CHROMOSOME ABERRATIONS; CYTOGENETICS; FANCONI ANEMIA; FEMALE; HETEROZYGOTE; HUMANS; LYMPHOCYTES; MALE; MITOMYCIN; RADIATION, IONIZING;

EID: 39049094697     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112060     Document Type: Article

References (36)

1. Auerbach AD, Wolman SR: Susceptibility of Fanconi's anemia fibroblasts to chromosome damage by carcinogens. Nature 261:494-496 (1976).
2. Auerbach AD, Warburton D, Bloom AD, Chaganti RSK: Prenatal detection of the Fanconi anemia gene by cytogenetic methods. Am J Hum Genet 31:77-81 (1979).
3. Auerbach AD, Rogtako A, Schroeder-Kurth TM: International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 73:391-396 (1989).
4. Barquinero JF, Barrios L, Ribas M, Egozcue J, Caballín MR: Cytogenetic sensitivity of three Fanconi anemia heterozygotes to bleomycin and ionizing radiation. Cancer Genet Cytogenet 124:80-83 (2001).
5. Beninson D, Lloyd DC, Natarajan AT, Obe G, Preston RJ, Sasaki MS: Biological dosimetry: Chromosomal aberration analysis for dose assessment. IAEA: Technical Reports Series N8 260, Vienna (1986).
6. Bessho T: Induction of DNA replication-mediated double strand breaks by psoralen DNA interstrand cross-links. J Biol Chem 278:5250-5254 (2003).
7. Bigelow SB, Rary JM, Bender MA: G2 chromosomal radio-sensitivity in Fanconi's anemia. Mutat Res 63:189-199 (1979).
8. Burnet NG, Wurm R, Tait DM, Peacock JH: Cellular sensitivity and low dose-rate recovery in Fanconi anaemia fibroblasts. Br J Radiol 67:579-583 (1994).
9. Casado JA, Nuňez MI, Segovia JC, de Almodovar JMR, Bueren JA: Non-homologous end-joining defect in Fanconi anemia hematopoietic cells exposed to ionizing radiation. Radiat Res 164:635-664 (2005).
10. Cohen MM, Simpson SJ, Honig GR, Maurer HS, Nicklas JW, Martin AO: The identification of Fanconi anemia genotypes by clastogen stress. Am J Hum Genet 34:794-810 (1982).
11. D'Andrea AD, Grompe M: The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 3:23-34 (2003).
12. Darroudi F, Vyas RC, Vermeulen S, Natarajan AT: G2 radio sensitivity of cells derived from cancer-prone individuals. Mutat Res 328:83-90 (1995).
13. Djuzenova CS, Flentje M: Characterization of Fanconi anemia fibroblasts in terms of clonogenic survival and DNA damage assessed by the comet assay. Med Sci Monit 8:421-430 (2002).
14. Dokal I, Chase A, Morgan NV, Coulthard S, Hall G, et al: Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations. Br J Haematol 3:813-816 (1996).
15. Dronkert ML, Kanaar R: Repair of DNA interstrand crosslinks. Mutat Res 486:217-247 (2001).
16. Duckworth-Rysiecki G, Taylor AM: Effects of ionizing radiation on cells from Fanconi's anemia patients. Cancer Res 45:416-420 (1985).
17. Duckworth-Rysiecki G, Hulten M, Mann J, Taylor AMR: Clinical and cytogenetic diversity in Fanconi's anaemia. J Med Genet 21:197-203 (1984).
18. Heddle JA, Lue CB, Saunders EF, Benz RD: Sensitivity to five mutagens in Fanconi's anemia as measured by the micronucleus method. Cancer Res 38:2983-2988 (1978).
19. Higurashi M, Conen PE: In vitro chromosomal radio sensitivity in 'chromosomal breakage' syndromes. Cancer 32:380-383 (1973).
20. ISCN: International system of cytogenetic nomenclature for acquired chromosome aberrations, Harnden DG, Klinger HP (eds), published in collaboration with Cytogenetic Cell Genetics (S. Karger, Basel 1985).
21. Joenje, H, Patel KJ: The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2:446-457 (2001).
22. Kalb R, Duerr M, Wagner M, Herterich S, Gross M, et al: Lack of sensitivity of primary Fanconi's anemia fibroblasts to UV and ionizing radiation. Radiat Res 161:318-325 (2004).
23. Kwee ML, Poll EHA, van de Kemp JJP, de Koning H, Eriksson AW, Joenje H: Unusual response to bifunctional alkylating agents in a case of Fanconi anemia. Hum Genet 64:348-387 (1983).
24. Leong T, Borg M, McKay M: Clinical and cellular radiosensitivity in inherited human syndromes. Clin Oncol 16:206-209 (2004).
25. MacMillan ML, Auerbach AD, Davies SM, Defor TE, Gillio A, et al: Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol 109:121-129 (2000).
26. Marcou Y, D'Andrea A, Jeggo PA, Plowman PN: Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother Oncol 60:75-79 (2001).
27. Marx MP, Smith S, Heyns AD, van Tonder IZ: Fanconi's anemia: a cytogenetic study on lymphocyte and bone marrow cultures utilizing 1, 2:3, 4-diepoxybutane. Cancer Genet Cytogenet 9:51-60 (1983).
28. Pearson T, Jansen S, Havenga C, Stones DK, Joubert G: Fanconi anemia: a statistical evaluation of cytogenetic results obtained from South African families. Cancer Genet Cytogenet 126:52-55 (2001).
29. Rothfuss A, Grompe M: Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol Cell Biol 24:123-134 (2004).
30. Saleh-Gohari N, Helleday T: Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res 32:3683-3688 (2004).
31. Sasaki MS, Tonomura A: A high susceptibility of Fanconi's anemia to chromosome breakage by DNA crosslink agents. Cancer Res 33:1829-1835 (1973).
32. Schroeder TM, Anschütz F, Knopp A: Spontane Chromosomenaberrationen bei familiärer Panmyelopathie. Humangenetik 1:194-196 (1964).
33. Schroeder TM, Tilgen D, Kruger J, Vogel F: Formal genetics of Fanconi's anemia. Hum Genet 32:257-288 (1976).
34. Sobeck A, Stone S, Costanzo V, Graaf B, Reuter T, et al: Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol Cell Biol 26:425-437 (2006).
35. Verlander PC, Kaporis A, Liu Q, Zhang Q, Seligsohn U, Auerbach AD: Carrier frequency of the IVS4 + 4A→T mutation of the Fanconi anemia gene FAC in the Ashkenazi jewish population. Blood 86:4034-4038 (1995).
36. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, et al: Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aero digestive tract. J Natl Cancer Inst 90:1393-1399 (1998).